Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

TG Therapeutics, Inc. (NKB2.F)

Compare
32.37
-1.07
(-3.20%)
As of 12:10:05 PM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
264,790
233,662
2,785
6,689
152
Cost of Revenue
30,941
14,131
265
790
--
Gross Profit
233,849
219,531
2,520
5,899
152
Operating Expense
234,354
198,898
195,359
350,669
273,746
Operating Income
-505
20,633
-192,839
-344,770
-273,594
Net Non Operating Interest Income Expense
-19,398
-12,615
-10,191
-5,638
-6,329
Other Income Expense
6,018
5,044
4,695
2,307
542
Pretax Income
-13,885
13,062
-198,335
-348,101
-279,381
Tax Provision
479
390
--
--
--
Net Income Common Stockholders
-14,364
12,672
-198,335
-348,101
-279,381
Diluted NI Available to Com Stockholders
-14,364
12,672
-198,335
-348,101
-279,381
Basic EPS
-0.10
0.09
-1.46
-2.63
-2.42
Diluted EPS
-0.10
0.09
-1.46
-2.63
-2.42
Basic Average Shares
144,783.03
141,955.11
135,411.26
132,222.75
115,333.69
Diluted Average Shares
159,318.98
148,508.47
135,411.26
132,222.75
115,333.69
Total Operating Income as Reported
-505
20,633
-192,839
-344,770
-273,594
Total Expenses
265,295
213,029
195,624
351,459
273,746
Net Income from Continuing & Discontinued Operation
-14,364
12,672
-198,335
-348,101
-279,381
Normalized Income
-14,364
12,672
-198,335
-348,101
-279,381
Interest Expense
19,398
12,615
10,191
5,638
6,329
Net Interest Income
-19,398
-12,615
-10,191
-5,638
-6,329
EBIT
5,513
25,677
-188,144
-342,463
-273,052
EBITDA
5,822
26,100
-187,629
-341,969
-272,678
Reconciled Cost of Revenue
30,941
14,131
265
790
--
Reconciled Depreciation
309
423
515
494
374
Net Income from Continuing Operation Net Minority Interest
-14,364
12,672
-198,335
-348,101
-279,381
Normalized EBITDA
5,822
26,100
-187,629
-341,969
-272,678
Tax Rate for Calcs
0
0
--
--
--
12/31/2020 - 10/23/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ICY.HA Incyte Corp
64.94
-3.79%
 
25K.MU Karyopharm Therapeutics Inc
0.5920
0.00%
 
ICY.DU Incyte Corp
65.22
-3.72%
 
ICY.F Incyte Corporation
66.78
-5.06%
 
GNPX Genprex, Inc.
0.3348
-3.79%
 
ONCY Oncolytics Biotech Inc.
0.6414
-3.28%
 
INCY Incyte Corporation
69.72
-0.77%
 
SYRS Syros Pharmaceuticals, Inc.
0.0824
+0.49%
 
DRUG Bright Minds Biosciences Inc.
32.69
-6.32%
 
HUMA Humacyte, Inc.
3.2379
+5.99%